Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries
Background Substandard and falsified medicines in Africa are a major public health concern. Access to quality medical products in African countries is governed in large part by two major entities at the national level: the regulatory authority and the procurement agency. The importance of national r...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20523211.2024.2436898 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841551942633914368 |
|---|---|
| author | Jillian C. Kohler Mariangela Castro-Arteaga Saher Panjwani David Mukanga Murray M. Lumpkin Bonface Fundafunda Anthony B. Kapeta Chimwemwe Chamdimba Anna S. Y. Wong Kristin N. Harper Charles Preston |
| author_facet | Jillian C. Kohler Mariangela Castro-Arteaga Saher Panjwani David Mukanga Murray M. Lumpkin Bonface Fundafunda Anthony B. Kapeta Chimwemwe Chamdimba Anna S. Y. Wong Kristin N. Harper Charles Preston |
| author_sort | Jillian C. Kohler |
| collection | DOAJ |
| description | Background Substandard and falsified medicines in Africa are a major public health concern. Access to quality medical products in African countries is governed in large part by two major entities at the national level: the regulatory authority and the procurement agency. The importance of national regulators in ensuring quality medical products is well known. The interplay between the national regulator and the national procurement agency also has a significant impact on access to quality medicines but is less understood. This study’s aim was to characterise the regulatory-procurement interface – the intersection of decision-making in these two spheres – using publicly available data from five African countries.Methods For the five target countries, we adapted criteria from WHO’s 2018 Pharmaceutical System Transparency and Accountability Assessment Tool to identify key national policies and practices around the nexus of medicines regulation and procurement.Results Though legal and policy frameworks enabling best practices in procurement were often in place, implementation and enforcement of these practices appear to be key areas for strengthening. In addition, we documented a lack of publicly available information related to the role that quality plays in selecting medical products. Finally, none of the five countries have publicly published the results of their selection decisions with key product details, making it difficult to assess whether basic quality standards are being met.Conclusion Based on these findings, one of the most important next steps for improving the effectiveness and transparency of national procurement is for procurement agencies to publish detailed quality selection criteria and an up-to-date list of the medical products they have purchased, with key product information. We hope these findings can help inform the conversation about implementing and enforcing best practices at the regulatory-procurement interface, with the goal of improving access to quality versions of medical products in Africa and globally. |
| format | Article |
| id | doaj-art-c7f7159283fe48848fb5510e932bac93 |
| institution | Kabale University |
| issn | 2052-3211 |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of Pharmaceutical Policy and Practice |
| spelling | doaj-art-c7f7159283fe48848fb5510e932bac932025-01-09T14:27:43ZengTaylor & Francis GroupJournal of Pharmaceutical Policy and Practice2052-32112025-12-0118110.1080/20523211.2024.2436898Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countriesJillian C. Kohler0Mariangela Castro-Arteaga1Saher Panjwani2David Mukanga3Murray M. Lumpkin4Bonface Fundafunda5Anthony B. Kapeta6Chimwemwe Chamdimba7Anna S. Y. Wong8Kristin N. Harper9Charles Preston10Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, CanadaDalla Lana School of Public Health, University of Toronto, Toronto, CanadaDepartment of Philosophy, Rotman Institute of Philosophy, Western University, London, CanadaBill & Melinda Gates Foundation, Seattle, WA, USABill & Melinda Gates Foundation, Seattle, WA, USAAfrica Resource Centre, Cape Town, South AfricaAUDA-NEPAD, Midrand, South AfricaAUDA-NEPAD, Midrand, South AfricaLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, CanadaHarper Health & Science Communications LLC, Seattle, WA, USABill & Melinda Gates Foundation, Seattle, WA, USABackground Substandard and falsified medicines in Africa are a major public health concern. Access to quality medical products in African countries is governed in large part by two major entities at the national level: the regulatory authority and the procurement agency. The importance of national regulators in ensuring quality medical products is well known. The interplay between the national regulator and the national procurement agency also has a significant impact on access to quality medicines but is less understood. This study’s aim was to characterise the regulatory-procurement interface – the intersection of decision-making in these two spheres – using publicly available data from five African countries.Methods For the five target countries, we adapted criteria from WHO’s 2018 Pharmaceutical System Transparency and Accountability Assessment Tool to identify key national policies and practices around the nexus of medicines regulation and procurement.Results Though legal and policy frameworks enabling best practices in procurement were often in place, implementation and enforcement of these practices appear to be key areas for strengthening. In addition, we documented a lack of publicly available information related to the role that quality plays in selecting medical products. Finally, none of the five countries have publicly published the results of their selection decisions with key product details, making it difficult to assess whether basic quality standards are being met.Conclusion Based on these findings, one of the most important next steps for improving the effectiveness and transparency of national procurement is for procurement agencies to publish detailed quality selection criteria and an up-to-date list of the medical products they have purchased, with key product information. We hope these findings can help inform the conversation about implementing and enforcing best practices at the regulatory-procurement interface, with the goal of improving access to quality versions of medical products in Africa and globally.https://www.tandfonline.com/doi/10.1080/20523211.2024.2436898National procurement agencynational regulatory authoritysubstandard and falsified medicinesregulatory-procurement interfacePharmaceutical System Transparency and Accountability Assessment Toolaccess to medicines |
| spellingShingle | Jillian C. Kohler Mariangela Castro-Arteaga Saher Panjwani David Mukanga Murray M. Lumpkin Bonface Fundafunda Anthony B. Kapeta Chimwemwe Chamdimba Anna S. Y. Wong Kristin N. Harper Charles Preston Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries Journal of Pharmaceutical Policy and Practice National procurement agency national regulatory authority substandard and falsified medicines regulatory-procurement interface Pharmaceutical System Transparency and Accountability Assessment Tool access to medicines |
| title | Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries |
| title_full | Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries |
| title_fullStr | Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries |
| title_full_unstemmed | Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries |
| title_short | Understanding the regulatory-procurement interface for medicines in Africa via publicly available information on standards, implementation, and enforcement in five countries |
| title_sort | understanding the regulatory procurement interface for medicines in africa via publicly available information on standards implementation and enforcement in five countries |
| topic | National procurement agency national regulatory authority substandard and falsified medicines regulatory-procurement interface Pharmaceutical System Transparency and Accountability Assessment Tool access to medicines |
| url | https://www.tandfonline.com/doi/10.1080/20523211.2024.2436898 |
| work_keys_str_mv | AT jillianckohler understandingtheregulatoryprocurementinterfaceformedicinesinafricaviapubliclyavailableinformationonstandardsimplementationandenforcementinfivecountries AT mariangelacastroarteaga understandingtheregulatoryprocurementinterfaceformedicinesinafricaviapubliclyavailableinformationonstandardsimplementationandenforcementinfivecountries AT saherpanjwani understandingtheregulatoryprocurementinterfaceformedicinesinafricaviapubliclyavailableinformationonstandardsimplementationandenforcementinfivecountries AT davidmukanga understandingtheregulatoryprocurementinterfaceformedicinesinafricaviapubliclyavailableinformationonstandardsimplementationandenforcementinfivecountries AT murraymlumpkin understandingtheregulatoryprocurementinterfaceformedicinesinafricaviapubliclyavailableinformationonstandardsimplementationandenforcementinfivecountries AT bonfacefundafunda understandingtheregulatoryprocurementinterfaceformedicinesinafricaviapubliclyavailableinformationonstandardsimplementationandenforcementinfivecountries AT anthonybkapeta understandingtheregulatoryprocurementinterfaceformedicinesinafricaviapubliclyavailableinformationonstandardsimplementationandenforcementinfivecountries AT chimwemwechamdimba understandingtheregulatoryprocurementinterfaceformedicinesinafricaviapubliclyavailableinformationonstandardsimplementationandenforcementinfivecountries AT annasywong understandingtheregulatoryprocurementinterfaceformedicinesinafricaviapubliclyavailableinformationonstandardsimplementationandenforcementinfivecountries AT kristinnharper understandingtheregulatoryprocurementinterfaceformedicinesinafricaviapubliclyavailableinformationonstandardsimplementationandenforcementinfivecountries AT charlespreston understandingtheregulatoryprocurementinterfaceformedicinesinafricaviapubliclyavailableinformationonstandardsimplementationandenforcementinfivecountries |